TVTX logo

Travere Therapeutics, Inc. (TVTX) Operating profit

annual operating profit:

-$256.18M+$120.56M(+32.00%)
December 31, 2024

Summary

  • As of today (September 16, 2025), TVTX annual operating income is -$256.18 million, with the most recent change of +$120.56 million (+32.00%) on December 31, 2024.
  • During the last 3 years, TVTX annual operating profit has fallen by -$116.68 million (-83.64%).
  • TVTX annual operating profit is now -36597614.29% below its all-time high of -$700.00, reached on February 28, 2011.

Performance

TVTX Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXincome statement metrics

quarterly operating profit:

-$12.65M+$30.02M(+70.36%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TVTX quarterly operating income is -$12.65 million, with the most recent change of +$30.02 million (+70.36%) on June 30, 2025.
  • Over the past year, TVTX quarterly operating profit has increased by +$54.40 million (+81.13%).
  • TVTX quarterly operating profit is now -6325100.00% below its all-time high of $200.00, reached on February 1, 2009.

Performance

TVTX quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXincome statement metrics

TTM operating profit:

-$170.68M+$54.40M(+24.17%)
June 30, 2025

Summary

  • As of today (September 16, 2025), TVTX TTM operating income is -$170.68 million, with the most recent change of +$54.40 million (+24.17%) on June 30, 2025.
  • Over the past year, TVTX TTM operating profit has increased by +$145.56 million (+46.03%).
  • TVTX TTM operating profit is now -42670900.00% below its all-time high of -$400.00, reached on May 1, 2008.

Performance

TVTX TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

TVTX Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+32.0%+81.1%+46.0%
3 y3 years-83.6%+79.1%+7.4%
5 y5 years-156.7%+32.8%-127.9%

TVTX Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-83.6%+32.0%at high+86.3%at high+51.9%
5 y5-year-239.9%+32.0%at high+86.3%-147.0%+51.9%
alltimeall time<-9999.0%+32.0%<-9999.0%+86.3%<-9999.0%+51.9%

TVTX Operating profit History

DateAnnualQuarterlyTTM
Jun 2025
-
-$12.65M(-70.4%)
-$170.68M(-24.2%)
Mar 2025
-
-$42.67M(-28.1%)
-$225.09M(-12.1%)
Dec 2024
-$256.18M(-32.0%)
-$59.33M(+5.9%)
-$256.18M(-8.4%)
Sep 2024
-
-$56.03M(-16.4%)
-$279.69M(-11.6%)
Jun 2024
-
-$67.05M(-9.1%)
-$316.25M(-5.6%)
Mar 2024
-
-$73.77M(-10.9%)
-$334.94M(-4.6%)
Dec 2023
-$376.74M(+17.8%)
-$82.84M(-10.5%)
-$350.93M(-1.1%)
Sep 2023
-
-$92.58M(+8.0%)
-$354.80M(+2.9%)
Jun 2023
-
-$85.74M(-4.5%)
-$344.82M(+7.9%)
Mar 2023
-
-$89.77M(+3.5%)
-$319.62M(+11.4%)
Dec 2022
-$319.81M(+129.2%)
-$86.70M(+5.0%)
-$286.90M(+15.2%)
Sep 2022
-
-$82.60M(+36.4%)
-$249.09M(+35.1%)
Jun 2022
-
-$60.54M(+6.1%)
-$184.33M(+17.0%)
Mar 2022
-
-$57.05M(+16.7%)
-$157.59M(+13.0%)
Dec 2021
-$139.50M(+85.1%)
-$48.89M(+173.9%)
-$139.50M(+20.4%)
Sep 2021
-
-$17.85M(-47.2%)
-$115.83M(+3.1%)
Jun 2021
-
-$33.81M(-13.2%)
-$112.33M(+15.4%)
Mar 2021
-
-$38.96M(+54.5%)
-$97.35M(+29.2%)
Dec 2020
-$75.38M(-24.5%)
-$25.21M(+75.7%)
-$75.38M(+9.1%)
Sep 2020
-
-$14.35M(-23.8%)
-$69.10M(-7.7%)
Jun 2020
-
-$18.82M(+10.8%)
-$74.89M(-16.1%)
Mar 2020
-
-$16.99M(-10.3%)
-$89.24M(-10.6%)
Dec 2019
-$99.81M(+45.3%)
-$18.94M(-6.0%)
-$99.81M(+3.3%)
Sep 2019
-
-$20.14M(-39.3%)
-$96.66M(+1.2%)
Jun 2019
-
-$33.18M(+20.4%)
-$95.50M(+16.9%)
Mar 2019
-
-$27.56M(+74.6%)
-$81.72M(+19.4%)
Dec 2018
-$68.69M(+143.9%)
-$15.78M(-16.9%)
-$68.45M(+18.2%)
Sep 2018
-
-$18.98M(-2.2%)
-$57.89M(+31.7%)
Jun 2018
-
-$19.40M(+35.8%)
-$43.96M(+26.1%)
Mar 2018
-
-$14.29M(+173.5%)
-$34.87M(+10.2%)
Dec 2017
-$28.17M
-$5.22M(+3.5%)
-$31.65M(-14.5%)
Sep 2017
-
-$5.05M(-51.1%)
-$37.00M(-11.6%)
Jun 2017
-
-$10.31M(-6.8%)
-$41.86M(+4.3%)
DateAnnualQuarterlyTTM
Mar 2017
-
-$11.06M(+4.6%)
-$40.14M(+15.9%)
Dec 2016
-$34.62M(+7.3%)
-$10.58M(+6.8%)
-$34.62M(+6.6%)
Sep 2016
-
-$9.90M(+15.3%)
-$32.49M(+3.3%)
Jun 2016
-
-$8.59M(+54.9%)
-$31.47M(+5.9%)
Mar 2016
-
-$5.55M(-34.4%)
-$29.70M(-7.9%)
Dec 2015
-$32.26M(-59.6%)
-$8.45M(-4.8%)
-$32.26M(-24.1%)
Sep 2015
-
-$8.88M(+30.1%)
-$42.51M(-25.5%)
Jun 2015
-
-$6.82M(-15.8%)
-$57.07M(-19.3%)
Mar 2015
-
-$8.10M(-56.7%)
-$70.75M(-10.8%)
Dec 2014
-$79.81M(+222.2%)
-$18.70M(-20.2%)
-$79.30M(+9.4%)
Sep 2014
-
-$23.44M(+14.3%)
-$72.47M(+34.5%)
Jun 2014
-
-$20.50M(+23.1%)
-$53.88M(+48.9%)
Mar 2014
-
-$16.65M(+40.3%)
-$36.19M(+66.1%)
Dec 2013
-$24.77M(-18.1%)
-$11.87M(+144.6%)
-$21.79M(-45.7%)
Sep 2013
-
-$4.85M(+72.4%)
-$40.17M(+13.7%)
Jun 2013
-
-$2.82M(+25.1%)
-$35.31M(+8.7%)
Mar 2013
-
-$2.25M(-92.6%)
-$32.50M(+7.4%)
Dec 2012
-$30.26M(>+9900.0%)
-$30.25M(<-9900.0%)
-$30.25M(>+9900.0%)
Nov 2011
-
$0.00(0.0%)
-$600.00(-14.3%)
Aug 2011
-
$0.00(0.0%)
-$700.00(0.0%)
May 2011
-
$0.00(-100.0%)
-$700.00(0.0%)
Feb 2011
-$700.00(-53.3%)
-$600.00(+500.0%)
-$700.00(+40.0%)
Nov 2010
-
-$100.00(<-9900.0%)
-$500.00(+25.0%)
Aug 2010
-
$0.00(0.0%)
-$400.00(-20.0%)
May 2010
-
$0.00(-100.0%)
-$500.00(-66.7%)
Feb 2010
-$1500.00(+7.1%)
-$400.00(<-9900.0%)
-$1500.00(+66.7%)
Nov 2009
-
$0.00(-100.0%)
-$900.00(-59.1%)
Aug 2009
-
-$100.00(-90.0%)
-$2200.00(+4.8%)
May 2009
-
-$1000.00(-600.0%)
-$2100.00(+40.0%)
Feb 2009
-$1400.00(-97.3%)
$200.00(-115.4%)
-$1500.00(-11.8%)
Nov 2008
-
-$1300.00(<-9900.0%)
-$1700.00(+325.0%)
Aug 2008
-
$0.00(-100.0%)
-$400.00(0.0%)
May 2008
-
-$400.00
-$400.00
Feb 2008
-$52.00K
-
-

FAQ

  • What is Travere Therapeutics, Inc. annual operating income?
  • What is the all time high annual operating profit for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. annual operating profit year-on-year change?
  • What is Travere Therapeutics, Inc. quarterly operating income?
  • What is the all time high quarterly operating profit for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. quarterly operating profit year-on-year change?
  • What is Travere Therapeutics, Inc. TTM operating income?
  • What is the all time high TTM operating profit for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. TTM operating profit year-on-year change?

What is Travere Therapeutics, Inc. annual operating income?

The current annual operating profit of TVTX is -$256.18M

What is the all time high annual operating profit for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high annual operating income is -$700.00

What is Travere Therapeutics, Inc. annual operating profit year-on-year change?

Over the past year, TVTX annual operating income has changed by +$120.56M (+32.00%)

What is Travere Therapeutics, Inc. quarterly operating income?

The current quarterly operating profit of TVTX is -$12.65M

What is the all time high quarterly operating profit for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high quarterly operating income is $200.00

What is Travere Therapeutics, Inc. quarterly operating profit year-on-year change?

Over the past year, TVTX quarterly operating income has changed by +$54.40M (+81.13%)

What is Travere Therapeutics, Inc. TTM operating income?

The current TTM operating profit of TVTX is -$170.68M

What is the all time high TTM operating profit for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high TTM operating income is -$400.00

What is Travere Therapeutics, Inc. TTM operating profit year-on-year change?

Over the past year, TVTX TTM operating income has changed by +$145.56M (+46.03%)
On this page